Prosecution Insights
Last updated: May 28, 2026
Application No. 18/572,036

ESTER COMPRISING HYDRATABLE CONCENTRATED SURFACTANT COMPOSITION

Non-Final OA §102§103
Filed
Dec 19, 2023
Priority
Jul 02, 2021 — EU 21183528.5 +1 more
Examiner
ELHILO, EISA B
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
CONOPCO, INC.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1197 granted / 1439 resolved
+18.2% vs TC avg
Strong +16% interview lift
Without
With
+15.8%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
37 currently pending
Career history
1461
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
61.5%
+21.5% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
12.5%
-27.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1439 resolved cases

Office Action

§102 §103
Claims 1-14 are pending in this application. DETAILED ACTION Notice of Pre-AIA or AIA Status 1 The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 2 This application contains the following inventions or groups of inventions which are not so linked as to form a single general inventive concept under PCT Rule 13.1. In accordance with 37 CFR 1.499, applicant is required, in reply to this action, to elect a single invention to which the claims must be restricted. This application contains the following inventions or groups of inventions which are not so linked as to form a single general inventive concept under PCT Rule 13.1. In accordance with 37 CFR 1.499, applicant is required, in reply to this action, to elect a single invention to which the claims must be restricted. Group I, claims 1-6 , drawn to a hydratable concentrated surfactant composition. Group II, claims 7-14, drawn to a method for making a wash composition comprising the steps of combining a hydratable concentrated surfactant composition, agitating and/or shearing the mix and producing the wash composition. The groups of inventions listed above do not relate to a single general inventive concept under PCT Rule 13.1 because, under PCT Rule 13.2, they lack the same or corresponding special technical features for the following reasons: The claims lack unity of invention because even though the inventions of these groups require the technical feature of a composition of group I, this technical feature is not a special technical feature as it does not make a contribution over the prior art in view of Zhou et al. (WO 2019000394 A1). Zhou et al. (WO’ 394 A1) teaches a sulfate-free cleaning composition comprising anionic surfactant, amphoteric or zwitterionic surfactant, water and alkanolamine of fatty acids, fatty acid ester (see abstract and pages 16-17, Examples). A telephone call was made to Edward A. Squillante on February 19, 2026 to request an oral election to the above restriction requirement. The applicant elected Group 1, claims 1-6. Election of claims 1-6 is acknowledged. Claims 7-14 are withdrawn from further consideration by the examiner, 37 CFR 1.142(b), as being drawn to a non-elected invention. Therefore, claims 1-6 are pending in this application. Claim Rejections - 35 USC § 102 3 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. 4 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-5 are rejected under 35 U.S.C. 102(a)1 as being anticipated by Zhou et al. (WO 2019000394 A1). Zhou et al. (WO’ 394 A1) teaches a cleaning composition comprising anionic surfactants include sodium lauroyl sarcosinate, amphoteric surfactants include coco-betaine, amide derivatives include cocamide in the amounts of 3% and 2.5% by wt., water in an amount of 81.45% and glyceryl oleate (glyceryl mono ester) in the amount of 1% and 2.5 % as claimed in claim 1 (see pages 16-17, Examples D and F and claim 1), wherein the weight percentage of oxygen in glyceryl oleate (C21H40O4) = 64/356 x 100 = 17.98% which is within the claimed range as claimed in claim 1 and wherein the composition is free of oil and sulfate based surfactants as claimed in claim 1 (see pages 16-17, Examples D and F and claim 1), and wherein the composition also comprises anionic surfactants include acyl isethionates, acyl taurates and acyl glycinates as claimed in claims 2-5 (see claim 3). Zhou et al. (WO’ 394 A1) teaches all the limitations of the instant claims. Hence, Zhou et al. (WO’ 394 A1) anticipates the claims. Claim Rejections - 35 USC § 103 5 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 6 is rejected under 35 U.S.C. 103 as being unpatentable over Zhou et al. (WO 2019000394 A1) in view of Guskey et al. (US 2014/0121268 A1). Zhou et al. (WO’ 394 A1) teaches a cleaning composition comprising anionic surfactant amphoteric surfactant, amide derivatives include cocamide in the amounts of 3% and 2.5% by wt., water in an amount of 81.45% and glyceryl oleate (glyceryl mono ester) in the amount of 1% and 2.5 % as claimed (see pages 16-17, Examples D and F and claim 1). The instant claims differ from the teaching of Zhou et al. (WO’ 394 A1) by reciting a composition comprising a resorcinol and niacinamide as claimed in claim 6. Guskey et al. (US’ 268 A1) in analogous art of cleaning formulation, teaches a cleaning composition comprising resorcinol and niacinamide as claimed in claim 6 (see page 4, paragraph, 0042). Therefore, in view of the teaching of Guskey et al. (US’ 268 A1), it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention, to be motivated to modify the cleaning composition of Zhou et al. (WO’ 394 A1) by incorporating resorcinol and niacinamide as taught by Guskey et al. (US’ 268 A1) to arrive at the claimed invention. Such a modification would be obvious because the person of the ordinary skill in the art would expect that the use of resorcinol and niacinamide as taught by Guskey et al. (US’ 268 A1) would be similarly useful and applicable to the analogous cleaning composition taught by Zhou et al. (WO’ 394 A1), absent unexpected result. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to EISA B ELHILO whose telephone number is (571)272-1315. The examiner can normally be reached Monday-Friday, 7:00 AM to 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at (571)272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EISA B ELHILO/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Dec 19, 2023
Application Filed
Mar 03, 2026
Non-Final Rejection mailed — §102, §103
May 11, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637634
NEUTRAL PH CLEANING FORMULATION
2y 8m to grant Granted May 26, 2026
Patent 12622858
ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF
4y 4m to grant Granted May 12, 2026
Patent 12624308
BIODEGRADABLE DELIVERY PARTICLES
3y 0m to grant Granted May 12, 2026
Patent 12622853
COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND A PARTICULAR AMINO SILICONE
1y 11m to grant Granted May 12, 2026
Patent 12624215
CATIONIC DYES AND USES THEREOF
1y 10m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
99%
With Interview (+15.8%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1439 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month